 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Teva Pharmaceutical Industries (NYSE:TEVA  Get Free Report) had its price objective hoisted by equities research analysts at UBS Group from $8.00 to $11.00 in a research report issued on...

Teva Pharmaceutical Industries (NYSE:TEVA) PT Raised to $11.00 at UBS Group

Investors in Teva Pharmaceutical Industries Ltd (TEVA) saw new options become available today, for the November 3rd expiration. At Stock Options Channel, our YieldBoost formula has looked up and...

November 3rd Options Now Available For Teva Pharmaceutical Industries

Delving into the intrinsic value, financial strength, and growth prospects of Teva Pharmaceutical IndustriesRelated Stocks: TEVA...

Unveiling Teva Pharmaceutical Industries (TEVA)'s Value: Is It Really Priced Right? A ...

In recent trading, shares of Teva Pharmaceutical Industries Ltd (TEVA) have crossed above the average analyst 12-month target price of 10.43, changing hands for 10.56/share. When a stock...

Teva Pharmaceutical Industries Reaches Analyst Target Price

This is a signal that TEVA's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Teva Pharmaceutical Industries (TEVA, $10.33) RSI Indicator left the overbought zone on September 13, 2023

This price move may be construed as a buy signal, as it indicates the trend is shifting higher...

Teva Pharmaceutical Industries (TEVA, $10.04) 50-day Moving Average moved above its 200-day Moving Average on September 11, 2023

Teva Pharmaceutical Industries Limited (TEVA) Morgan Stanley 21st Annual Global Healthcare Conference 2023 (Transcript...

Teva Pharmaceutical Industries Limited (TEVA) Morgan Stanley 21st Annual Global Healthcare Conference 2023 (Transcript)

Teva Pharmaceutical Industries Limited (NYSE:TEVA  Free Report)  Equities researchers at Zacks Research reduced their Q1 2024 EPS estimates for shares of Teva Pharmaceutical Industries...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) to Post Q1 2024 Earnings of $0.48 Per Share, Zacks Research Forecasts

Investors in Teva Pharmaceutical Industries Ltd (TEVA) saw new options become available today, for the October 27th expiration. At Stock Options Channel, our YieldBoost formula has looked up and...

October 27th Options Now Available For Teva Pharmaceutical Industries (TEVA)

Bank of New York Mellon Corp lessened its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA Free Report) by 3.2% in the first quarter, according to its most recent filing with the SEC. The firm owned 1,805,368 shares of the companys stock after selling 60,399 shares during the ...

Bank of New York Mellon Corp Has $15.98 Million Stock Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Watchers	26,231
52-Wk Low	$7.09
52-Wk High	$11.45

Market Cap	$11.6B
Volume (M)	7.14M
52-Wk High	$11.45
52-Wk Low	$7.09

TEVA Teva- Pharmaceutical Industries Ltd. - ADR

About

Feed

News

Sentiment

Earnings

Fundamentals